首页|盐酸氨溴索对重症肺炎TNF-α、hs-CRP等炎症因子水平变化的影响及临床治疗效果分析

盐酸氨溴索对重症肺炎TNF-α、hs-CRP等炎症因子水平变化的影响及临床治疗效果分析

扫码查看
目的 探讨盐酸氨溴索对重症肺炎患者的治疗效果,及对TNF-α、hs-CRP等炎症因子水平的影响.方法 回顾性分析2014年12月~2016年8月在广东省第二人民医院呼吸内科接受治疗的70例重症肺炎患者的临床资料,根据其治疗方式分为对照组30例和观察组40例,对照组给予常规治疗,观察组在常规治疗的基础上给予盐酸氨溴索治疗.观察2组患者的治疗效果,比较2组患者治疗前后血清炎症细胞因子水平、肺功能、咳嗽咳痰症状积分的差异.结果 观察组治疗有效率为97.50%,明显高于对照组(80.00%);2组患者治疗前血清炎症细胞因子水平差异无统计学意义,治疗后,观察组IL-6、IL-8、hs-CRP和TNF-α水平均低于对照组;2组患者治疗前肺功能指标差异无统计学意义,治疗后,观察组FVC、FEV1和FEV1/FVC水平均高于对照组;治疗前2组患者症状积分差异无统计学意义,治疗后,观察组咳嗽、痰量、咳嗽难易程度和哮鸣音得分均低于对照组.结论 盐酸氨溴索对重症肺炎有较好的治疗效果,可明显降低患者TNF-α、hs-CRP等炎症细胞因子水平,改善相关症状,具有良好的应用价值.
Analysis of ambroxol hydrochloride on inflammatory factor level changes of TNF-alpha and hs-CRP in severe pneumonia and clinical therapeutic effect
Objective To investigate the therapeutic effect of ambroxol hydrochloride on severe pneumonia, and the influence on the inflammatory cytokines of TNF-alpha and hs-CRP etc.MethodsThe clinical data of 70 patients with severe pneumonia patients treated in our hospital from December 2014 to August 2016 were retrospectively analyzed.The patients were divided into control group(n=30) and observation group(n=40) according to the treatment methods, the control group was given routine treatment, the observation group was given ambroxol hydrochloride on the basis of conventional treatment.The therapeutic effect of the two groups was observed, the differences of serum levels of inflammatory cytokines, pulmonary function, cough and expectoration symptom scores of the two groups were compared before and after treatment.ResultsThe effective rate of the observation group was 97.50%, which was significantly higher than that of the control group(80.00%);There was no significant difference in serum inflammatory cytokine levels between the two groups before treatment, after treatment,the levels of IL-6, IL-8, hs-CRP and TNF-alpha the observation group were lower than those in the control group;There was no significant difference in the indexes of lung function between the two groups before treatment.After treatment, the levels of FVC, FEV1 and FEV1/FVC in the observation group were higher than those in the control group;There was no significant difference in symptom score between the two groups before treatment.After treatment, cough, sputum volume, cough ease and wheezing scores in the observation group were lower than in the control group.ConclusionAmbroxol hydrochloride has a good therapeutic effect on severe pneumonia,which can significantly reduce the levels of inflammatory cytokines such as TNF-α and hs-CRP, and improve the related symptoms, and has good application value.

ambroxolpneumoniainflammatory cytokinespulmonary function

颜文森、李斌、王燕、江小运、王钧

展开 >

广东省第二人民医院 呼吸内科,广东 广州 510317

氨溴索 肺炎 炎症细胞因子 肺功能

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(6)
  • 15
  • 14